MarketCap
Facebook
X
TelegramQuarterly report 2024-Q2
added 08-07-2024
Silk Road Medical, Inc Total Assets 2011-2026 | SILK
Total Assets — these are all the resources owned by the business that have economic value. They are used to operate the business, generate profit, and ensure the company’s stability.Main categories of assets
Current assets (used within one year):
- Cash and cash equivalents
- Accounts receivable (amounts owed by customers)
- Inventory of goods, raw materials, and supplies
- Short-term investments
- Fixed assets (buildings, machinery, equipment)
- Intangible assets (brands, patents, software)
- Long-term investments
- Goodwill (reputational value from mergers)
Assets represent an objective measure of a business's value, reflecting everything behind it: physical infrastructure, technology, customer base, and financial resources. A high share of liquid assets such as cash indicates a company’s financial flexibility and its ability to maintain stability in changing market conditions.
Asset analysis helps assess how effectively a company utilizes its resources to generate revenue and profit, reflecting its operational efficiency and ability to convert invested capital into financial results.
Annual Total Assets Silk Road Medical, Inc
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 265 M | 270 M | 157 M | 179 M | 137 M | 40.9 M | 43.1 M | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 270 M | 40.9 M | 156 M |
Quarterly Total Assets Silk Road Medical, Inc
| 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 270 M | 252 M | 265 M | 261 M | 263 M | 260 M | 270 M | 163 M | 163 M | 143 M | 157 M | 166 M | 168 M | 170 M | 179 M | 179 M | 179 M | 179 M | 137 M | 137 M | 137 M | 137 M | 42.7 M | 40.9 M | 40.9 M | 40.9 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 270 M | 40.9 M | 169 M |
Total Assets of other stocks in the Medical devices industry
| Issuer | Total Assets | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Align Technology
ALGN
|
6.21 B | $ 176.83 | 5.97 % | $ 13.2 B |  USA |
 |
Alphatec Holdings
ATEC
|
791 M | $ 11.66 | 5.71 % | $ 1.75 B | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
224 M | - | - | $ 1.77 B | USA |
 |
Acutus Medical
AFIB
|
54 M | - | -26.83 % | $ 2.62 M | USA |
 |
AxoGen
AXGN
|
222 M | $ 34.0 | 9.71 % | $ 1.57 B | USA |
 |
AdaptHealth Corp.
AHCO
|
4.32 B | $ 12.18 | 2.01 % | $ 1.65 B | USA |
 |
Allied Healthcare Products
AHPI
|
19.7 M | - | 3.58 % | $ 2.21 M | USA |
 |
Conformis
CFMS
|
94 M | - | - | $ 16.4 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
10.6 M | - | -5.86 % | $ 30.6 M | USA |
 |
Bio-Rad Laboratories
BIO
|
9.36 B | $ 281.15 | 1.13 % | $ 7.93 B | USA |
 |
Cardiovascular Systems
CSII
|
323 M | - | 0.15 % | $ 844 M | USA |
 |
Cytosorbents Corporation
CTSO
|
44.2 M | $ 0.62 | 1.67 % | $ 38.6 M | USA |
 |
Bruker Corporation
BRKR
|
5.81 B | $ 38.25 | 4.31 % | $ 5.7 K | USA |
 |
Boston Scientific Corporation
BSX
|
43.7 B | $ 62.56 | 1.15 % | $ 92.6 B | USA |
 |
Dynatronics Corporation
DYNT
|
15.4 M | - | 14.99 % | $ 929 K | USA |
 |
Apollo Endosurgery
APEN
|
110 M | - | - | $ 475 M | USA |
 |
Electromed
ELMD
|
53.8 M | $ 24.4 | 2.61 % | $ 206 M | USA |
 |
Second Sight Medical Products
EYES
|
39.4 M | - | -0.97 % | $ 54.4 M | USA |
 |
ClearPoint Neuro
CLPT
|
97.7 M | $ 9.17 | 1.1 % | $ 260 M | USA |
 |
GBS
GBS
|
8.25 M | - | -0.57 % | $ 7.12 M | USA |
 |
Globus Medical
GMED
|
5.3 B | $ 91.96 | 2.13 % | $ 12.4 B | USA |
 |
CryoLife, Inc.
CRY
|
789 M | - | -4.14 % | $ 702 M | USA |
 |
Avinger
AVGR
|
13.8 M | - | -20.74 % | $ 369 K | USA |
 |
Inogen
INGN
|
299 M | $ 6.67 | -1.91 % | $ 177 M | USA |
 |
Inspire Medical Systems
INSP
|
907 M | $ 53.38 | -1.89 % | $ 1.57 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
659 M | - | - | $ 3.31 B | USA |
 |
IRIDEX Corporation
IRIX
|
29.2 M | $ 1.03 | - | $ 17.4 M | USA |
 |
Integer Holdings Corporation
ITGR
|
3.41 B | $ 87.48 | 2.78 % | $ 3.04 B | USA |
 |
Invacare Corporation
IVC
|
771 M | - | - | $ 24.7 M | USA |
 |
Aziyo Biologics
AZYO
|
62.4 M | - | 1.37 % | $ 20.5 M | USA |
 |
Soliton, Inc.
SOLY
|
33.8 M | - | -1.42 % | $ 435 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
509 M | $ 16.01 | 1.59 % | $ 376 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
10.5 K | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
64.1 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
204 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
66.2 M | - | - | $ 111 M |  Canada |
 |
LivaNova PLC
LIVN
|
2.61 B | $ 64.66 | 1.76 % | $ 3.53 B |  Britain |
 |
LENSAR
LNSR
|
71.4 M | $ 5.53 | -1.78 % | $ 66.1 M | USA |
 |
Butterfly Network
BFLY
|
256 M | $ 4.14 | 2.22 % | $ 876 M | USA |
 |
Intersect ENT, Inc.
XENT
|
227 M | - | - | $ 955 M | USA |
 |
EDAP TMS S.A.
EDAP
|
91.5 M | $ 3.37 | -0.88 % | $ 126 M |  France |
 |
Myomo
MYO
|
38.6 M | $ 0.68 | 0.44 % | $ 28.5 M | USA |
 |
NanoVibronix
NAOV
|
3.63 M | - | - | $ 1.08 M | USA |
 |
BIOLASE
BIOL
|
35.1 M | - | -13.19 % | $ 166 K | USA |
 |
Delcath Systems
DCTH
|
124 M | $ 9.85 | 1.86 % | $ 353 M | USA |
 |
BioSig Technologies
BSGM
|
188 M | - | 37.08 % | $ 85.7 M | USA |
 |
Natus Medical Incorporated
NTUS
|
564 M | - | 1.94 % | $ 1.05 B | USA |
 |
Nevro Corp.
NVRO
|
554 M | - | - | $ 217 M | USA |